» Articles » PMID: 21540555

Autoimmune Melanocyte Destruction is Required for Robust CD8+ Memory T Cell Responses to Mouse Melanoma

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2011 May 5
PMID 21540555
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

A link between autoimmunity and improved antitumor immunity has long been recognized, although the exact mechanistic relationship between these two phenomena remains unclear. In the present study we have found that vitiligo, the autoimmune destruction of melanocytes, generates self antigen required for mounting persistent and protective memory CD8+ T cell responses to melanoma. Vitiligo developed in approximately 60% of mice that were depleted of regulatory CD4+ T cells and then subjected to surgical excision of large established B16 melanomas. Mice with vitiligo generated 10-fold larger populations of CD8+ memory T cells specific for shared melanoma/melanocyte antigens. CD8+ T cells in mice with vitiligo acquired phenotypic and functional characteristics of effector memory, suggesting that they were supported by ongoing antigen stimulation. Such responses were not generated in melanocyte-deficient mice, indicating a requirement for melanocyte destruction in maintaining CD8+ T cell immunity to melanoma. Vitiligo-associated memory CD8+ T cells provided durable tumor protection, were capable of mounting a rapid recall response to melanoma, and did not demonstrate phenotypic or functional signs of exhaustion even after many months of exposure to antigen. This work establishes melanocyte destruction as a key determinant of lasting melanoma-reactive immune responses, thus illustrating that immune-mediated destruction of normal tissues can perpetuate adaptive immune responses to cancer.

Citing Articles

Depletion of conventional CD4 T cells is required for robust priming and dissemination of tumor antigen-specific CD8 T cells in the setting of anti-CD4 therapy.

Ramirez D, Dragnev C, Searles T, Spicer N, Chen T, Lines J J Immunother Cancer. 2024; 12(11).

PMID: 39521617 PMC: 11552015. DOI: 10.1136/jitc-2024-010170.


CD39 Is Expressed on Functional Effector and Tissue-resident Memory CD8+ T Cells.

Isaacs J, Degefu H, Chen T, Kleist S, Musial S, Ford M J Immunol. 2024; 213(5):588-599.

PMID: 38975728 PMC: 11333163. DOI: 10.4049/jimmunol.2400151.


Cancer Therapy-induced Dermatotoxicity as a Window to Understanding Skin Immunity.

Jimenez-Andrade Y, Flesher J, Park J Hematol Oncol Clin North Am. 2024; 38(5):1011-1025.

PMID: 38866636 PMC: 11368641. DOI: 10.1016/j.hoc.2024.05.002.


Transient regulatory-T-cell interruption promotes skin-resident memory T cells mediated tumor protection.

Zhao S, Wu S, Jiang S, Zhou X, Zhao G, Wang B Sci Rep. 2023; 13(1):10898.

PMID: 37407600 PMC: 10322828. DOI: 10.1038/s41598-023-36884-w.


Leveraging a cuproptosis-based signature to predict the prognosis and drug sensitivity of cutaneous melanoma.

Liu D, Yang F, Zhang T, Mao R J Transl Med. 2023; 21(1):57.

PMID: 36717900 PMC: 9885583. DOI: 10.1186/s12967-023-03891-4.


References
1.
Schreurs M, de Boer A, Schmidt A, Figdor C, Adema G . Cloning, expression and tissue distribution of the murine homologue of the melanocyte lineage-specific antigen gp100. Melanoma Res. 1998; 7(6):463-70. DOI: 10.1097/00008390-199712000-00004. View

2.
Daniels G, Sanchez-Perez L, Diaz R, Kottke T, Thompson J, Lai M . A simple method to cure established tumors by inflammatory killing of normal cells. Nat Biotechnol. 2004; 22(9):1125-32. DOI: 10.1038/nbt1007. View

3.
van den Boorn J, Konijnenberg D, Tjin E, Picavet D, Meeuwenoord N, Filippov D . Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG. PLoS One. 2010; 5(5):e10626. PMC: 2869359. DOI: 10.1371/journal.pone.0010626. View

4.
Ji Q, Gondek D, Hurwitz A . Provision of granulocyte-macrophage colony-stimulating factor converts an autoimmune response to a self-antigen into an antitumor response. J Immunol. 2005; 175(3):1456-63. DOI: 10.4049/jimmunol.175.3.1456. View

5.
Wherry E, Blattman J, Murali-Krishna K, van der Most R, Ahmed R . Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol. 2003; 77(8):4911-27. PMC: 152117. DOI: 10.1128/jvi.77.8.4911-4927.2003. View